Nancy Brown MD

Clinical Trials

• Racial Variation in ACE--Genetic and Physiologic Bases Start of enrollment: 1997 Sep 01

  Completed

• Genes and Fibrinolytic Capacity of Human Endothelium Start of enrollment: 2000 Aug 01
• Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF) Start of enrollment: 2005 Apr 01

  Completed

  Phase 2, Phase 3

• Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema Start of enrollment: 2007 Sep 01

  Terminated

  Phase 1

• Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome Start of enrollment: 2008 Mar 01

  Completed

  Phase 4

• Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3 Start of enrollment: 2007 Dec 01

  Completed

  Not Applicable

• Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis Start of enrollment: 2008 Aug 01

  Completed

  Phase 2

• Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i Start of enrollment: 2006 Dec 01

  Completed

  Not Applicable

• The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans Start of enrollment: 2009 Sep 01

  Completed

  Phase 4

• Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3 Start of enrollment: 2010 Jan 01

  Terminated

  Phase 3

• Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis Start of enrollment: 2011 Aug 01

  Terminated

  Phase 4

• Pharmacogenetics of Ace Inhibitor-Associated Angioedema Start of enrollment: 2011 Nov 01

  Completed

  Not Applicable

• Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema Start of enrollment: 2011 Aug 01

  Terminated

  Phase 4

• Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome Start of enrollment: 2012 Feb 01

  Terminated

  Phase 4

• Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle. Start of enrollment: 2014 Apr 01

  Completed

  Phase 4

• Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure Start of enrollment: 2014 Jun 01

  Completed

  Not Applicable

• Comparative Effects of Aspirin and NHP-544C Start of enrollment: 2014 Jul 01

  Completed

  Not Applicable

• Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2 Start of enrollment: 2017 Sep 01

  Withdrawn

  Phase 2

• Cardiovascular Effects of GLP-1 Receptor Activation Start of enrollment: 2017 May 01

  Completed

  Phase 4

• Soluble Epoxide Hydrolase Inhibition and Insulin Resistance Start of enrollment: 2018 May 17

  Completed

  Phase 2

• Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2 Start of enrollment: 2019 Nov 01

  ACTIVE_NOT_RECRUITING

  PHASE4

• Join now to see all